Clinical biomedical research of indoleamine 2,3-dioxygenase: update on current available reports from Southeast Asia
Beuy Joob1, Sora Yasri2, Viroj Wiwanitkit3
1Private Academic Consultant Bangkok, Thailand.
Abstract:
Indoleamine 2,3-dioxygenase is an important enzyme in human, which plays roles in the rate-limiting first step in tryptophan catabolism. Indoleamine 2,3-dioxygenase is currently studied by research groups worldwide. Association between Indoleamine 2,3-dioxygenase and medial disorders in clinical medicine is proposed and is an interesting topic in clinical biochemical reasearch. Here, the author briefly reviews and discusses on the available important scientific reports on Indoleamine 2,3-dioxygenase from tropical Southeast Asia.
More Related Videos
08:31Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
12:10An Experimental and Bioinformatics Protocol for RNA-seq Analyses of Photoperiodic Diapause in the Asian Tiger Mosquito, Aedes albopictus
Published on: November 30, 2014
